Wire Stories

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of…

4 years ago

Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with…

4 years ago

Locix’s Warehouse Intelligence Solution Deployment Named a Recipient of Supply & Demand Chain Executive’s Top Supply Chain Projects Awards

This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium, and large enterprises across a…

4 years ago

Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split

Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB)…

4 years ago

Entegris and CMC Materials Receive China Antitrust Clearance for Pending Acquisition

Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG) and CMC Materials,…

4 years ago

Growing Number of CAGR of 4.3% from 2022 to 2030, mTOR Inhibitors Market Size to USD 9,445 Mn by 2030 Report By Acumen Research and Consulting

Acumen Research and Consulting recently published report titled “mTOR Inhibitors Market Size, Share, Analysis Report and Region Forecast, 2022 -…

4 years ago

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced. Interim analysis shows a 91%…

4 years ago

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced. Interim analysis shows a 91%…

4 years ago

Thailand Telecoms, Mobile and Broadband Market Analyses Report 2022 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to ResearchAndMarkets.com's offering. Thailand…

4 years ago

Thailand Telecoms, Mobile and Broadband Market Analyses Report 2022 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to ResearchAndMarkets.com's offering. Thailand…

4 years ago